{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003977","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.185069+00:00","generated_at":"2026-05-27T08:23:31.742905+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BriaCell completes 15:1 share consolidation to comply with Nasdaq listing","bullets":["Consolidation effective Jan 24, 2025; post-consolidation shares begin trading Jan 29, 2025.","Shares reduced from 44,204,061 to 2,946,940; no fractional shares issued.","New CUSIP: 107930208; tickers BCTX and BCTXW unchanged on Nasdaq and TSX.","Exercise prices and conversion ratios on convertible securities proportionately adjusted."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003977","json":"https://secwatch.observer/filing/0001493152-25-003977.json","markdown":"https://secwatch.observer/filing/0001493152-25-003977.md","text":"https://secwatch.observer/filing/0001493152-25-003977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225003977/0001493152-25-003977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225003977/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:23:31.742905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}